ArticleResearch square2026

Progression-Free Survival versus Overall Survival in Patients with PSA-Recurrent Prostate Cancer: Long-Term Analysis of a Randomized Phase 2 Trial of pTVG-HP versus Placebo.

Douglas McNeel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.